title: Quebrachitol-induced gastroprotection against acute gastric lesions: role of prostaglandins, nitric oxide and K+ ATP channels.
abstract: The effect of Quebrachitol (2-O-methyl-L-inositol), a bioactive component from Magonia glabrata fruit extract was investigated against gastric damage induced by absolute ethanol (96%, 0.2 ml/animal) and indomethacin (30 mg/kg, p.o.), in mice. Quebrachitol at oral doses of 12.5, 25, and 50mg/kg markedly attenuated the gastric lesions induced by ethanol to the extent of 69%, 64%, and 53% and against indomethacin by 55%, 59%, and 26%, respectively. While pretreatment with TRPV1 antagonist capsazepine (5mg/kg, i.p.) failed to block effectively the gastroprotective effect of quebrachitol (25mg/kg) against ethanol damage, the non-selective cyclooxygenase inhibitor indomethacin (10mg/kg, p.o.), almost abolished it. Furthermore, quebrachitol effect was significantly reduced in mice pretreated with L-NAME, or glibenclamide, the respective inhibitors of nitric oxide synthase and K(+)(ATP) channel activation. Thus we provide the first evidence that quebrachitol reduces the gastric damage induced by ethanol and indomethacin, at least in part, by mechanisms that involve endogenous prostaglandins, nitric oxide release, and or the activation of K(+)(ATP) channels.
authors.affiliation: Department of Physiology and Pharmacology, Faculty of Medicine, Federal University of Ceará, P.O. Box 3157, 60430-270 Fortaleza, CE, Brazil.
authors.forename: T M
authors.initials: TM
authors.lastname: de Olinda
authors.forename: T L G
authors.initials: TL
authors.lastname: Lemos
authors.forename: L L
authors.initials: LL
authors.lastname: Machado
authors.forename: V S
authors.initials: VS
authors.lastname: Rao
authors.forename: F A
authors.initials: FA
authors.lastname: Santos
mesh_terms: D000818:Animals; D001120:Arginine / Q000494:pharmacology; D002211:Capsaicin / Q000031:analogs & derivatives / Q000494:pharmacology; D003981:Diazoxide / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D000431:Ethanol / Q000633:toxicity; D005905:Glyburide / Q000494:pharmacology; D007213:Indomethacin / Q000633:toxicity; D007294:Inositol / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D054086:KATP Channels / Q000502:physiology*; D008297:Male; D051379:Mice; D016595:Misoprostol / Q000494:pharmacology; D015394:Molecular Structure; D019331:NG-Nitroarginine Methyl Ester / Q000494:pharmacology; D009569:Nitric Oxide / Q000502:physiology*; D008517:Phytotherapy; D011453:Prostaglandins / Q000502:physiology*; D013276:Stomach Ulcer / Q000139:chemically induced / Q000517:prevention & control*
chemical_list: D054086:KATP Channels; D011453:Prostaglandins; D016595:Misoprostol; D009569:Nitric Oxide; D000431:Ethanol; D007294:Inositol; D001120:Arginine; C056476:quebrachitol; C071423:capsazepine; D003981:Diazoxide; D002211:Capsaicin; D005905:Glyburide; D019331:NG-Nitroarginine Methyl Ester; D007213:Indomethacin